The latest quarterly R&D expense is $24.79 Million with a QoQ Growth of -16.60%. Research and Development (R&D) expenses represent the costs incurred by a company in developing new products, services, or processes.
Q2 FY2026 (2026-06-30).
Reported quarterly R&D expense; no daily interpolation. Q2 FY2026 (2026-06-30): $24.79M.
$24.79M
$24.79 Million
Q2 FY2026 · 2026-06-30
-16.60%
vs. $29.72M prior quarter
15
Quarters of data available
| Period | R&D Expense | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2026Period end 2026-06-30 | $24.79M | -16.60% | -30.79% |
| Q1 FY2026Period end 2026-03-31 | $29.72M | -0.97% | -20.60% |
| Q4 FY2025Period end 2025-12-31 | $30.01M | -1.45% | -8.83% |
| Q3 FY2025Period end 2025-09-30 | $30.46M | -14.96% | +4.33% |
| Q2 FY2025Period end 2025-06-30 | $35.82M | -4.32% | +31.09% |
| Q1 FY2025Period end 2025-03-31 | $37.43M | +13.71% | N/A |
| Q4 FY2024Period end 2024-12-31 | $32.92M | +12.77% | +91.81% |
| Q3 FY2024Period end 2024-09-30 | $29.19M | +6.85% | +113.96% |
| Q2 FY2024Period end 2024-06-30 | $27.32M | N/A | +162.58% |
| Q1 FY2024Period end 2024-03-31 | $22.48K | -99.87% | -99.74% |
| Q4 FY2023Period end 2023-12-31 | $17.16M | +25.79% | +156.43% |
| Q3 FY2023Period end 2023-09-30 | $13.64M | +31.13% | N/A |
| Q2 FY2023Period end 2023-06-30 | $10.40M | +19.45% | N/A |
| Q1 FY2023Period end 2023-03-31 | $8.71M | +30.15% | N/A |
| Q4 FY2022Period end 2022-12-31 | $6.69M | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.
